Oral probiotics in coronavirus disease 2019: connecting the gut–lung axis to viral pathogenesis, inflammation, secondary infection and clinical trials

Oral probiotics in coronavirus disease 2019: connecting the gut–lung axis to viral pathogenesis, inflammation, secondary infection and clinical trials

Defined as helpful live bacteria that can provide medical advantages to the host when administered in tolerable amounts, oral probiotics might be worth considering as a possible preventive or therapeutic modality to mitigate coronavirus disease 2019 (COVID-19) symptom severity. This hypothesis stems...

Full description

Bibliographic Details
Main Authors: P. Baindara, R. Chakraborty, Z.M. Holliday, S.M. Mandal, A.G. Schrum
Format: Article
Language:English
Published: Elsevier 2021-03-01
Series:New Microbes and New Infections
Subjects:
Coronavirus disease 2019
gut–lung axis
gut microbiome
probiotics
secondary infection
severe acute respiratory syndrome coronavirus 2
Online Access:http://www.sciencedirect.com/science/article/pii/S2052297521000019

Internet

http://www.sciencedirect.com/science/article/pii/S2052297521000019

Similar Items